EMPHYSEMA: AN OVERVIEW

Swaraj G. Surwase; Ganesh S. Lad; Shyamlila B. Bavage; Nandkishor B. Bavage

EMPHYSEMA: AN OVERVIEW

Authors: Swaraj G. Surwase, Ganesh S. Lad, Shyamlila B. Bavage, Nandkishor B. Bavage

Unique Paper ID: 152388
Volume: 8
Issue: 3
PageNo: 162-168

Keywords: Chronic-bronchitis chronic bronchitis lungs respire COPD CT Chest X-Ray.

Abstract:
Emphysema can be defined as loss of lung capacity, chronic enlargement of the airways to the posterior bronchioles, and destruction of alveolar walls. It can be classified under the common name of chronic obstructive pulmonary disease (COPD). The Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) has defined COPD as "a common, preventable and incurable disease caused by persistent respiratory symptoms and airway obstruction and or alveolar abnormalities often caused by exposure to harmful substances, particles or particles". . People with COPD having the harder problem in breathing, which can lead to shortness of breath and or fatigue. At the onset of the disease, people with COPD may feel short of breath when exercising. As the disease progresses, it may be difficult to exhale (inhale) or inhale (inhale). A person with COPD may have obstructive bronchiolitis (bron-kee-oh-lite-is), emphysema, or a combination of both. The value of these conditions varies from person to person. [1] Asthma is another disease that causes airway obstruction, sometimes making it difficult to breathe, but asthma is not included in the definition of COPD. Some people have a combination of COPD and asthma. Chronic bronchitis is no longer considered a form of COPD, although health care professionals still use the term to describe a productive cough patient for three months in two consecutive years. Emphysema is primarily a diagnosis of disease that affects the airways away from the final bronchiole. It is characterized by an abnormal continuous expansion of the airways of the lungs by the destruction of their walls without fibrosis and destruction of the lung parenchyma by loss of strength.

Download article

email to a friend

Cite This Article

ISSN: 2349-6002
Volume: 8
Issue: 3
PageNo: 162-168

EMPHYSEMA: AN OVERVIEW

Available:https://ijirt.org/Article?manuscript=152388

09 Nov, 2021

REVIEW ON DIABETES MELLITUS

17 Oct, 2021

DRUG REPURPOSING IN ANTIVIRAL RESEARCH: A REVIEW

08 Aug, 2021

RHINO-ORBITAL MUCORMYCOSIS ASSOCIATED WITH COVID-19

08 Aug, 2021

THE PRINCIPLES OF SKIN TISSUE ENGINEERING

08 Aug, 2021

A REVIEW ON LYME BORRELIOSIS

31 Jul, 2021

AWARENESS ABOUT BANNED DRUG

31 Jul, 2021

APPLICATION AND THE PRODUCTION OF RADIOPHARMACEUTICAL’S

30 Jul, 2021

ANTHELMINTIC ACTIVITY OF SOME MEDICINAL PLANTS

30 Jul, 2021

A REVIEW ON DRUMSTICK PLANTS (MORINGA OLEIFERA) MEDICAL USES AND NUTRITIONAL PROPERTIES

29 Jul, 2021

PHARMACOTHERAY OF HYPERTENSION

Impact Factor
8.01 (Year 2024)

UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry